1. Chen, Xiaoxiang, Xu, Mu, Xu, Xueni, Sun, Huilin, Wang, Shukui. 2020. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. In Molecular cancer, 19, 106. doi:10.1186/s12943-020-01220-7. https://pubmed.ncbi.nlm.nih.gov/32552762/
2. Meng, Liping, Lin, Hui, Huang, Xingxiao, Peng, Fang, Wu, Shengjie. 2022. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA. In Cell death & disease, 13, 38. doi:10.1038/s41419-021-04484-z. https://pubmed.ncbi.nlm.nih.gov/35013106/
3. Zheng, Yang, Li, Yunqi, Ran, Xianwen, Sun, Yong, Wu, Jian. 2022. Mettl14 mediates the inflammatory response of macrophages in atherosclerosis through the NF-κB/IL-6 signaling pathway. In Cellular and molecular life sciences : CMLS, 79, 311. doi:10.1007/s00018-022-04331-0. https://pubmed.ncbi.nlm.nih.gov/35598196/
4. Guan, Qian, Lin, Huiran, Miao, Lei, Zhuo, Zhenjian, He, Jing. 2022. Functions, mechanisms, and therapeutic implications of METTL14 in human cancer. In Journal of hematology & oncology, 15, 13. doi:10.1186/s13045-022-01231-5. https://pubmed.ncbi.nlm.nih.gov/35115038/
5. Dou, Xiaoyang, Huang, Lulu, Xiao, Yu, He, Chuan, Liu, Jun. . METTL14 is a chromatin regulator independent of its RNA N6-methyladenosine methyltransferase activity. In Protein & cell, 14, 683-697. doi:10.1093/procel/pwad009. https://pubmed.ncbi.nlm.nih.gov/37030005/
6. Lu, Weicheng, Yang, Xiaohua, Zhong, Weiqiang, Ma, Huijie, Xie, Jingdun. 2024. METTL14-mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP2. In The Journal of clinical investigation, 134, . doi:10.1172/JCI174847. https://pubmed.ncbi.nlm.nih.gov/38319733/
7. Jian, Dongdong, Wang, Ying, Jian, Liguo, Wang, Shuai, Li, Muwei. 2020. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications. In Theranostics, 10, 8939-8956. doi:10.7150/thno.45178. https://pubmed.ncbi.nlm.nih.gov/32802173/
8. Hou, Yichao, Zhang, Xintian, Yao, Han, Fang, Jing-Yuan, Meng, Xiangjun. 2023. METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53-wild-type cells. In EMBO reports, 24, e56325. doi:10.15252/embr.202256325. https://pubmed.ncbi.nlm.nih.gov/36794620/